Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 1 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in NZD
The 2 analysts offering 12 month price targets for AFT Pharmaceuticals Ltd have a median target of 3.63, with a high estimate of 4.60 and a low estimate of 2.65. The median estimate represents a 36.79% increase from the last price of 2.65.
High | 73.6% | 4.60 |
Med | 36.8% | 3.63 |
Low | 0.0% | 2.65 |
Dividends
Div growth (TTM) | 45.45% |
---|
More ▼
Earnings history & estimates in NZD
Average growth rate | +74.97% |
More ▼
Revenue history & estimates in NZD
Average growth rate | +16.82% |
More ▼